OASIS-6 : The Safety and Efficacy of Fondaparinux Versus Control Therapy in Patients With ST Segment Elevation Acute Myocardial Infarction

Clinical trial NCT00064428 · COMPLETED

Trial details

NCT number: NCT00064428
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Thromboembolism

Start date: 2003-08-01
Primary completion: 2006-02-01
Enrollment: 12092

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.